ArticleClinical practice and cases in emergency medicine2026
Atrial Fibrillation in a Young Patient Using High-dose Oral Diclofenac: A Case Report.
Article in Clinical practice and cases in emergency medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionDiclofenac sodium is a widely used medication for its analgesic and anti-inflammatory properties. Although the adverse effects of diclofenac are well described, diclofenac-associated new-onset atrial fibrillation in a young, healthy adult has not been previously reported. CASE REPORT: A 22-year-old man with severe pain following an ankle injury used diclofenac sodium at a dose of 50 mg orally three times daily for one week. At the end of the week, he presented to the emergency department (ED) complaining of palpitations for a few hours. The patient had no past medical history. His physical examination revealed no pathologic signs except for tachycardia and an irregularly irregular pulse rate. An electrocardiogram showed an irregularly irregular rhythm with a ventricular rate of 128 beats per minute (bpm) (rapid ventricular response) and absent P waves, consistent with atrial fibrillation. The patient was monitored in the ED, and a standard regimen of intravenous amiodarone was initiated for rate control. Approximately three hours after initiation, sinus rhythm returned and his heart rate stabilized at 60 bpm.
conclusionThis case report describes a possible association between diclofenac use and new-onset atrial fibrillation in a young, previously healthy individual. The findings highlight the need for awareness of the potential arrhythmogenic effects of diclofenac and underscore the importance of taking a careful drug history in patients presenting with unexplained atrial fibrillation.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.